Frode Jahnsen profile picture

Frode Jahnsen

Professor at University of Oslo

University of Oslo
Country flagNorway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Positions (1)

Publisher
source

Håvard Lindholm

University Name
.

University of Oslo

A fully funded three-year full-time PhD fellowship in cancer research is available at the Department of Pathology, Oslo University Hospital and Faculty of Medicine, University of Oslo. The Department of Pathology is the largest in Norway, with a strong research section organized into seven groups, focusing on cancer, immunopathology, inflammation, and neurodegenerative diseases. The position is available from May 1st, 2026, with flexibility for an earlier or later start date. The project is led by Dr. Håvard Lindholm and will be located in the laboratory of Professor Frode Jahnsen (jahnsenlab.org) at Oslo University Hospital, Rikshospitalet. It is a collaborative effort with Professor Hege Elisabeth Giercksky Russnes at Oslo University Hospital and Professor Daniel De Carvalho at Princess Margaret Cancer Centre, Toronto. All groups are internationally recognized experts in immunology, cancer, and bioinformatics. The research aims to explore how antiviral defense pathways can be harnessed to kill breast cancer cells. The team will sequence RNA from over 300 breast cancer patients, investigate the activation mechanisms of antiviral defense pathways in cell cultures, and perform bioinformatics analysis of large datasets. The work will be conducted in a modern molecular biology lab equipped with specialized instruments such as the P2 solo for Oxford Nanopore Sequencing and access to computational clusters for data analysis. Antiviral defense pathways are activated when double-stranded RNA (dsRNA) is expressed from the genome, typically only present during viral infection. Dysregulated pathways in cancer can lead to dsRNA expression, triggering innate immune responses that may kill cancer cells. This project seeks to understand the timing and location of dsRNA expression in cancer and how it can be targeted for future therapeutics. For more details, see the review at https://doi.org/10.1016/j.trecan.2022.09.001 . The successful candidate will perform Oxford Nanopore sequencing of RNA samples, conduct wet lab experiments on dsRNA fate in cells, create scripts for data analysis, and perform bioinformatic analysis of public datasets. While both wet lab and bioinformatics skills are valued, strong experience in one area is sufficient, as training will be provided by the experienced team. Applicants must hold an MSc in biology, immunology, medicine, bioinformatics, computational biology, informatics, or a related field. Experience in molecular biology techniques and bioinformatics is required; experience with library preparation, cell culture, RNA synthesis, and Python programming is a plus. Candidates must have fluent oral and written English skills and be highly motivated to address important scientific questions. To apply, submit an application letter, CV, MSc thesis, educational certificates, transcript of records, and letters of recommendation or contact details for 2-3 references via the electronic recruiting system. All documents should be in English or a Scandinavian language. Foreign applicants should include an explanation of their university's grading system. Interviews will require presentation of educational certificates and transcripts. This is an excellent opportunity to join a leading research environment and contribute to innovative cancer therapeutics. The position is fully funded for three years, including stipend and tuition. For further information, visit jahnsenlab.org or the application link below.

11 months ago

Articles (6)

The amino acid glutamine, and its derivatives glutamate and GABA, are pivotal for neurogenesis. However, how glutamine is mechanistically supplied to the cells in the neurogenic niches and its broader impact on neurodevelopment, remain poorly characterized. The Solute carrier family 38 member 1 (Slc38a1) exhibits high affinity for glutamine and accumulates glutamine in select cells. We investigated whether Slc38a1 is essential for neurogenesis and whether it has an impact on brain structure and function. Slc38a1 mRNA transcript and protein are widely expressed in the embryonic brain, including in the dorsal pallium and sub-pallium. At embryonic day 15.5, Slc38a1 localizes in neuronal stem cells in the ventricular zone in the forebrain, while it localizes in mature neurons in the sub-ventricular zone of the hindbrain. In the adult brain, Slc38a1 is not detected in neuronal stem cells in the sub-granular zone, however, it is highly enriched in mature local parvalbumin + and somatostatin + interneurons and ependyma. Analyses of single-cell RNA sequencing data further reveal that both the number of Slc38a1-expressing cells and the average transcript level of Slc38a1 are significantly higher in embryo brain cells compared to adults. In the embryo, Slc38a1 transcripts are particularly enriched in immature neuronal lineages and embryonic oligodendrocyte precursor populations, whereas in the adult, expression is more prominent in neural progenitor cells and radial glia. Disruption of Slc38a1 in mice impacts body weight, brain size and glutamatergic neuronal volume, while dendritic arborization is diminished and cellular life span is shortened. Altogether, Slc38a1 is essential for normal neurodevelopment, indirectly regulates adult neurogenesis in the sub-granular zone and influence neuronal morphology and cell viability.

Year:

2025

Motivation The emergence of high-resolution spatial transcriptomics platforms, such as VisiumHD, has enabled transcriptome-wide spatial profiling at near-single-cell resolution. However, existing analysis tools often lack scalability or compatibility with this new resolution, limiting their utility for multimodal cell type analysis. Results We present Easydecon, a lightweight and modular computational framework for spatial transcriptomics analysis using marker genes from single-cell RNA sequencing data. Easydecon integrates similarity-based label transfer with regression-based deconvolution in a two-phase strategy that first detects expression hotspots and then refines cell type assignments. We demonstrate its efficacy on colorectal cancer datasets, identifying spatially distinct immune and stromal compartments and resolving macrophage subsets with high accuracy. Easydecon supports integration with segmentation tools and outperforms established methods in speed, usability and cell type recovery. Availability and implementation Easydecon is implemented in Python, available at https://github.com/sinanugur/easydecon and PyPi.

Year:

2025

It has been reported that microsatellite instable (MSI) tumors in colorectal cancer (CRC) exhibit stronger anti-tumor responses than microsatellite stable (MSS) tumors. Analyzing scRNA-seq data from 185 CRC patients we found that immune, structural, and cancer cells in MSS tumors with high numbers of tumor-infiltrating CD8 T cells and macrophages (TAMs; CD8 hi TAM hi ) and CD8 low TAM hi tumors were enriched for pathways associated with anti- and pro-tumor responses, respectively. In CD8 hi TAM hi tumors, TAMs expressed an IFN-induced phenotype (e.g. GBP1, CXCL9, IFITM3 ) and high infiltration of GBP1 + TAMs was associated with better overall survival (n=941). High-resolution spatial transcriptomics (Visium HD) revealed that GBP1 + TAMs clustered with CXCL13 + IFNG+PDCD1+ CD8 T cells in tumoral niches, suggesting that GBP1 + TAMs were involved in recruitment and activation of tumor-reactive CD8 T cells. Together, we uncovered coordinated cellular programs across cell types in the microenvironment of MSS tumors, based on simple classification variables, that were strongly associated with prognosis.

Year:

2025

A large fraction of the intestinal microbiota is highly coated with secretory IgA, and bacteria-specific IgA is believed to shape the composition of the microbiota. A hallmark of the adaptive immune system is immunological memory to specific antigens. However, whether there is strong and persistent memory of secretory antibodies to bacterial antigens has not been determined. Here we show that ultra long-lived CD19 - CD45 - (age>20 years) plasma cells (PCs) residing in the human small intestine produce IgA that binds to most taxa of a diverse anaerobic microbiota culture. Long-lived CD19 - CD45 + (age>10 years) and short-lived CD19+CD45+ (age<2 years) PCs also produced IgA with broad bacterial reactivity. A clear correlation between high-binding and low-binding taxa was observed across the PC subsets. We also found that host PCs were depleted in acute intestinal graft versus host disease, a condition strongly associated with loss of microbiota diversity. Together, we show that bacterial antigens in the intestine induce an extremely stable, long-lasting humoral immune memory that may be important for the long-term stability and resilience of the intestinal microbiome.

Year:

2025

The gastrointestinal (GI) tract consists of connected organs, from the oral cavity to rectum, which function to ensure efficient nutrient uptake and barrier immunity. Diseases of the GI tract affect millions worldwide and as such there are now over 25 published single cell RNA-sequencing (scRNAseq) datasets surveying the GI tract, profiling specific anatomical regions, cell lineages, ages and diseases. To consolidate these efforts, we harmonised and integrated scRNAseq datasets across the whole GI tract from developing and adult human tissues, as well as newly generated data from preterm gut. We uniformly processed 385 samples from 189 healthy controls using a newly developed automated QC approach (scAutoQC). In total, our healthy reference contains ~1.1 million cells which we annotated to a total of 137 fine-grained cell states. We anchor 13 published and 1 unpublished GI disease datasets covering gastric and colorectal (CRC) cancers, celiac disease, ulcerative colitis (UC) and Crohn's disease (CD) to this reference, taking our atlas to a total of 1.6 million cells. We provide our atlas as a valuable resource to the community (available at gutcellatlas.org). Using this resource, we discover epithelial cell metaplasia arising from stem cells across intestinal inflammatory diseases (celiac, UC and CD) and CRC with transcriptional similarity to cells of the gastric and Brunner's glands. Whilst previously linked to mucosal healing, we now implicate these cells in inflammation through recruitment of immune cells including T cells and neutrophils, and through direct interactions with T cells. Overall, we discover a shift in paradigm whereby changes in stem cells during inflammation lead to altered mucosal tissue architecture, which in turn contributes to ongoing inflammation. These findings highlight that in addition to barrier function, epithelial cells actively contribute to progression of inflammation which may be a function applicable to other tissues and diseases.

Year:

2024

Summary Visium HD by 10X Genomics is the first commercially available platform capable of capturing full scale transcriptomic data paired with a reference morphology image from archived FFPE blocks at sub-cellular resolution. However, aggregation of capture regions to single cells poses challenges. Bin2cell reconstructs cells from the highest resolution data (2 μ m bins) by leveraging morphology image segmentation and gene expression information. It is compatible with established Python single cell and spatial transcriptomics software, and operates efficiently in a matter of minutes without requiring a GPU. We demonstrate improvements in downstream analysis when using the reconstructed cells over default 8 μ m bins on mouse brain and human colorectal cancer data. Availability and Implementation Bin2cell is available at https://github.com/Teichlab/bin2cell , along with documentation and usage examples, and can be installed from pip. Probe design functionality is available at https://github.com/Teichlab/gene2probe Contact [email protected] , [email protected] Supplementary information Supplementary data are available online.

Year:

2024

Collaborators (16)

Kourosh Saeb-Parsy

Reader

University of Cambridge

UNITED KINGDOM
View details

Ruoyan Li

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Diana Domanska

Senior researcher

Oslo University Hospital

NORWAY
View details

Christopher J Stewart

Professor of Human Microbiome Research

Newcastle University

UNITED KINGDOM
View details

Julio Saez-Rodriguez

Head of Research

European Bioinformatics Institute

UNITED KINGDOM
View details

Sarah Teichmann

University of Cambridge

UNITED KINGDOM
View details

Sheraz Yaqub

Full Professor of Surgery

University of Oslo

NORWAY
View details

Niladri Bhusan Pati

Assistant Professor

Manipal University

View details

nadav yayon

University of Cambridge

UNITED KINGDOM
View details

Sebastian Lobentanzer

Principal Investigator

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details

paul klenerman

University of Oxford

UNITED KINGDOM
View details

Kylie Renee James

University of New South Wales

AUSTRALIA
View details

Matthias Zilbauer

University of Cambridge

UNITED KINGDOM
View details

Alexander Predeus

Principal bioinformatician

Wellcome Sanger Institute

UNITED KINGDOM
View details

Chuan Xu

University of Cambridge

UNITED KINGDOM
View details

Simon Koplev

Assistant Professor at KTH Royal Institute of Technology

KTH Royal Institute of Technology

SWEDEN
View details